These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 1914756

  • 1. Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy.
    Miholic J, Orskov C, Holst JJ, Kotzerke J, Meyer HJ.
    Dig Dis Sci; 1991 Oct; 36(10):1361-70. PubMed ID: 1914756
    [Abstract] [Full Text] [Related]

  • 2. Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome.
    Gebhard B, Holst JJ, Biegelmayer C, Miholic J.
    Dig Dis Sci; 2001 Sep; 46(9):1915-23. PubMed ID: 11575444
    [Abstract] [Full Text] [Related]

  • 3. Postprandial release of glucagon-like peptide-1, pancreatic glucagon, and insulin after esophageal resection.
    Miholic J, Orskov C, Holst JJ, Kotzerke J, Pichlmayr R.
    Digestion; 1993 Sep; 54(2):73-8. PubMed ID: 8319842
    [Abstract] [Full Text] [Related]

  • 4. Secretion of glucagon-like peptide-1 and reactive hypoglycemia after partial gastrectomy.
    Andreasen JJ, Orskov C, Holst JJ.
    Digestion; 1994 Sep; 55(4):221-8. PubMed ID: 8063025
    [Abstract] [Full Text] [Related]

  • 5. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.
    Nauck MA, Niedereichholz U, Ettler R, Holst JJ, Orskov C, Ritzel R, Schmiegel WH.
    Am J Physiol; 1997 Nov; 273(5):E981-8. PubMed ID: 9374685
    [Abstract] [Full Text] [Related]

  • 6. Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.
    Meier JJ, Kemmeries G, Holst JJ, Nauck MA.
    Diabetes; 2005 Jul; 54(7):2212-8. PubMed ID: 15983224
    [Abstract] [Full Text] [Related]

  • 7. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
    Hücking K, Kostic Z, Pox C, Ritzel R, Holst JJ, Schmiegel W, Nauck MA.
    Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
    [Abstract] [Full Text] [Related]

  • 8. Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia.
    Toft-Nielsen M, Madsbad S, Holst JJ.
    Diabetologia; 1998 Oct; 41(10):1180-6. PubMed ID: 9794105
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide-1(7-36)amide in non-insulin dependent diabetes mellitus.
    Schirra J, Leicht P, Hildebrand P, Beglinger C, Arnold R, Göke B, Katschinski M.
    J Endocrinol; 1998 Jan; 156(1):177-86. PubMed ID: 9496247
    [Abstract] [Full Text] [Related]

  • 10. Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.
    Willms B, Werner J, Holst JJ, Orskov C, Creutzfeldt W, Nauck MA.
    J Clin Endocrinol Metab; 1996 Jan; 81(1):327-32. PubMed ID: 8550773
    [Abstract] [Full Text] [Related]

  • 11. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
    Gutniak MK, Juntti-Berggren L, Hellström PM, Guenifi A, Holst JJ, Efendic S.
    Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604
    [Abstract] [Full Text] [Related]

  • 12. A possible difference in the mechanism for postprandial hypoglycemia associated with dumping syndrome between patients with and without type 2 diabetes.
    Hamasaki H, Moriyama S, Yanai H.
    Obes Res Clin Pract; 2015 Aug; 9(6):622-4. PubMed ID: 26321136
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relation between gastric emptying of glucose and plasma concentrations of glucagon-like peptide-1.
    Wishart JM, Horowitz M, Morris HA, Jones KL, Nauck MA.
    Peptides; 1998 Aug; 19(6):1049-53. PubMed ID: 9700754
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans.
    Näslund E, Bogefors J, Skogar S, Grybäck P, Jacobsson H, Holst JJ, Hellström PM.
    Am J Physiol; 1999 Sep; 277(3):R910-6. PubMed ID: 10484511
    [Abstract] [Full Text] [Related]

  • 20. Endogenous GLP-1 regulates postprandial glycemia in humans: relative contributions of insulin, glucagon, and gastric emptying.
    Nicolaus M, Brödl J, Linke R, Woerle HJ, Göke B, Schirra J.
    J Clin Endocrinol Metab; 2011 Jan; 96(1):229-36. PubMed ID: 21047924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.